Grant: CIHR Fellowship
Direct Payment
$150,000.00
Memory Dysfunction in Schizophrenia and Parkinson's Disease: Investigating the Role of Dopamine using Pharmacological FMRI
FY 2012-13
Summary
Memory dysfunction is a major factor that impairs the quality of life for individuals suffering from a broad set of conditions, ranging from schizophrenia to healthy aging. To date, research has focused on how memory dysfunction relates to permanent structural changes in the brain. But emerging findings from animal research show that a neurotransmitter called dopamine, which is dysfunctional in many conditions that result in memory disorders, plays a crucial role in regulating how the brain forms memories. This opens the possibility that some clinical memory deficits may be chemical in nature and, thus, more treatable than previously believed. The proposed project uses a combination of cutting edge pharmacological and brain imaging techniques to assess how dopamine influences memory in the healthy and diseased human brain. The project aims to uncover (1) whether pharmacological manipulations of dopamine influence memory formation in humans, (2) the neural mechanisms underlying this modulation, (3) the extent to which memory deficits are caused by dopaminergic dysfunction in two disorders which are characterized by dopamine imbalance, schizophrenia and Parkinson's disease, and (4) how dopaminergic medications used to treat schizophrenia and Parkinson's disease influence the aspects of memory that are dopamine-modulated. The results of this project will provide new insights into the physiological basis of memory deficits and can be used to identify the specific aspects of memory which are most likely to be treatable with pharmacological intervention along with the aspects of memory which are least affected by dopaminergic dysfunction and on which patients with schizophrenia and Parkinson's disease can learn to rely.
Department
Program
CIHR Fellowship
Recipient
Location
New York, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
282492
Name
Duncan Katherine D
Region
New York
Country
United States of America
Orgtype
Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Memory Dysfunction in Schizophrenia and Parkinson's Disease: Investigating the Role of Dopamine using Pharmacological FMRI
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Cognitive Tests; D-Amphetamine; Dopamine; Fmri; Humans; Medication; Memory; Parkinson'S Disease; Pharmacology; Schizophrenia
Abstract
Memory dysfunction is a major factor that impairs the quality of life for individuals suffering from a broad set of conditions, ranging from schizophrenia to healthy aging. To date, research has focused on how memory dysfunction relates to permanent structural changes in the brain. But emerging findings from animal research show that a neurotransmitter called dopamine, which is dysfunctional in many conditions that result in memory disorders, plays a crucial role in regulating how the brain forms memories. This opens the possibility that some clinical memory deficits may be chemical in nature and, thus, more treatable than previously believed. The proposed project uses a combination of cutting edge pharmacological and brain imaging techniques to assess how dopamine influences memory in the healthy and diseased human brain. The project aims to uncover (1) whether pharmacological manipulations of dopamine influence memory formation in humans, (2) the neural mechanisms underlying this modulation, (3) the extent to which memory deficits are caused by dopaminergic dysfunction in two disorders which are characterized by dopamine imbalance, schizophrenia and Parkinson's disease, and (4) how dopaminergic medications used to treat schizophrenia and Parkinson's disease influence the aspects of memory that are dopamine-modulated. The results of this project will provide new insights into the physiological basis of memory deficits and can be used to identify the specific aspects of memory which are most likely to be treatable with pharmacological intervention along with the aspects of memory which are least affected by dopaminergic dysfunction and on which patients with schizophrenia and Parkinson's disease can learn to rely.
Competitiondate
201302
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Duncan, Katherine D
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~